...
首页> 外文期刊>Experimental parasitology >Novel solid dispersions of benznidazole: Preparation, dissolution profile and biological evaluation as alternative antichagasic drug delivery system
【24h】

Novel solid dispersions of benznidazole: Preparation, dissolution profile and biological evaluation as alternative antichagasic drug delivery system

机译:新型苯并硝唑固体分散体:制备,溶出度和生物学评估,作为替代的抗chachagas药物输送系统

获取原文
获取原文并翻译 | 示例
           

摘要

Solid dispersions (SD) of benznidazole (BNZ) in sodium deoxycholate (NaDC) or low-substituted hydroxypropylcellulose (L-HPC) were developed by freeze-drying process to improve the solubility of this low water-soluble drug and consequently, its trypanocidal activity. Although the dissolution studies showed a progressive decrease in the release rate of BNZ when formulated in the presence of NaDC, the increase in the surfactant concentration resulted in a better trypanocidal profile on epimastigotes, as well as in an enhancement of the unspecific cytotoxicity. However, such an effect was not so evident on amastigotes and in vivo (blood-trypomastigotes), where high concentrations of surfactant (BNZ:NaDC >= 1:6) experimented a loss of activity, correlating this fact with the minor cession of BNZ these formulations accomplished in acidic locations (i.e., dissolution test medium). According to the in vitro results, we reformulated the promising SD-1:3 (IC50 epimastigotes = 33.92 +/- 6.41 mu M, IC50 amastigotes = 0.40 +/- 0.05 mu M and LC50 = 183.87 +/- 12.30 mu M) replacing NaDC by L-HPC, which achieved the fastest dissolution profile. This fact, together with the safety this carrier ensures (LC50 > 256 mu M), prompted us to evaluate the cellulose SD in vivo, improving the effectiveness of its NaDC equivalent (%AUPC = 96.65% and 91.93%, respectively). The results compiled in the present work suggest these solid dispersions as alternative drug delivery systems to improve the limited chemotherapy of Chagas disease. (C) 2015 Elsevier Inc. All rights reserved.
机译:通过冷冻干燥工艺开发了苯并硝唑(BNZ)在脱氧胆酸钠(NaDC)或低取代羟丙基纤维素(L-HPC)中的固体分散体(SD),以提高这种低水溶性药物的溶解度,从而提高其锥虫杀灭活性。尽管在NaDC存在下配制时溶解研究显示BNZ的释放速率逐渐降低,但是表面活性剂浓度的增加导致副鞭毛者的锥虫杀灭性更好,并且非特异性细胞毒性增强。但是,这种作用在变形虫和体内(血锥虫)体内不是很明显,在那里高浓度的表面活性剂(BNZ:NaDC> = 1:6)实验性丧失活性,这与BNZ的轻微戒断相关。这些制剂在酸性位置(即溶出度测试介质)完成。根据体外结果,我们重新制定了有前途的SD-1:3(IC50淫羊tig = 33.92 +/- 6.41μM,IC50拟扁桃体= 0.40 +/- 0.05μM和LC50 = 183.87 +/- 12.30μM)替代L-HPC的NaDC,其溶出曲线最快。这一事实以及该载体可确保的安全性(LC50> 256μM)促使我们在体内评估纤维素SD,从而提高了其NaDC当量的有效性(%AUPC = 96.65%和91.93%)。在本工作中汇编的结果表明,这些固体分散体可作为替代药物递送系统,以改善南美锥虫病的有限化学疗法。 (C)2015 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号